CDEK by Data4ThePeople
Sign in Sign up
← All organizations

Neurelis, Inc.

For profit

Also known as: NEURALIS s.a. | Neurelis, Inc. | NEURELIS INC

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Feb 1, 2011

First marketed drug

Jan 10, 2020

Last known activity

Oct 16, 2023

Timeline

2000s

  1. Jun 1, 2007

    Neurelis, Inc.— Founded

2010s

  1. Dec 3, 2018

    Aegis Pharms— Acquired

  2. Dec 3, 2018

    Aegis Therapeutics— Acquired

2020s

  1. Jan 10, 2020

    diazepam— Marketing Organization

  2. Jan 10, 2020

    diazepam— NDA Secondary Org

Drugs by trial phase (3 distinct, 7 trials)

Phase 3 (1 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Subsidiaries (2 direct, 2 total across the full acquisition tree)

Recent trials (7)

Details

Founded
Encinatas, CA, US Jun 1, 2007
Last known activity
Oct 16, 2023